Avalon GloboCare Regains Compliance with Nasdaq Stockholders’ Equity Requirement, Launches Marketing for Automated Generative AI Video Platform
Avalon GloboCare Corp. (“Avalon” or the “Company”) , a diversified company focused on the development of precision diagnostic consumer products and the advancement of intellectual property in cellular therapy and generative AI publishing and software, announced that it received notice from The Nasdaq Stock Market LLC (“Nasdaq”) informing the Company that it has regained compliance […]